Advertisement

U.S. markets closed

S&P Futures
3,768.75
-20.75(-0.55%)
Dow Futures
30,607.00
-174.00(-0.57%)
Nasdaq Futures
11,467.00
-62.50(-0.54%)
Russell 2000 Futures
1,693.40
-14.60(-0.85%)
Crude Oil
106.14
+0.38(+0.36%)
Gold
1,805.20
-2.10(-0.12%)

Advertisement

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

22.17

-0.21

(-0.94%)

At close: 04:00PM EDT

21.00

-1.17

(-5.28%)

After hours:

06:37PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Inside Bar (Bearish)

View all chart patterns

Performance Outlook

Previous Close	22.38
Open	21.90
Bid	8.84 x 1400
Ask	22.00 x 900
Day's Range	21.70 - 22.44
52 Week Range	16.75 - 58.61
Volume	437,392
Avg. Volume	720,955

Market Cap	1.215B
Beta (5Y Monthly)	1.52
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AGIO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Agios Pharmaceuticals, Inc.
Technical Assessment: Bearish in the Intermediate-TermMarket sentiment remains in the tank and the stock market simply cannot put together a decent rally. The National Association of Active Investment Managers (NAAIM) exposure index has fallen back to 20%, an extremely low equity exposure and a very bearish stance toward equities. This is the second time the index has dropped to 20% in the past six weeks. The seven-week average of exposure has fallen to 30%, the lowest since the pandemic low, as well as in 2015, 2011, and 2008/2009.
Rating
Fair Value
Economic Moat
20 hours agoArgus Research